Jerman Michael Allen has filed 8 insider transactions across 4 companies since March 2024.
Most recent transaction: a grant/award of 5406 shares of Alaunos Therapeutics, Inc. ($TCRT) on January 12, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 12, 2026 | Alaunos Therapeutics, Inc. | $TCRT | Jerman Michael Allen | Not found | A | Common Stock | 5406 | $2.89 | 9,589.0000 | 2,231,829 | 129.24% | 0.24% |
| Nov. 21, 2025 | Alaunos Therapeutics, Inc. | $TCRT | Jerman Michael Allen | Not found | A | Common Stock | 4183 | $3.16 | 4,183.0000 | 2,231,829 | 9999.99% | 0.19% |
| July 15, 2025 | Alaunos Therapeutics, Inc. | $TCRT | Jerman Michael Allen | Not found | A | Employee Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 1,601,252 | 9999.99% | 0.62% |
| July 15, 2025 | Alaunos Therapeutics, Inc. | $TCRT | Jerman Michael Allen | Not found | A | Employee Stock Option (right to buy) | 3200 | $0.00 | 3,200.0000 | 1,601,252 | 9999.99% | 0.20% |
| April 1, 2025 | Inhibitor Therapeutics, Inc. | $INTI | Jerman Michael Allen | Director | A | Common Stock | 50000 | $0.00 | 80,411.0000 | 172,323,545 | 164.41% | 0.03% |
| Aug. 27, 2024 | Telomir Pharmaceuticals, Inc. | $TELO | Jerman Michael Allen | Director | A | Incentive Stock Options (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| April 1, 2024 | Inhibitor Therapeutics, Inc. | $INTI | Jerman Michael Allen | Director | A | Common Stock | 50000 | $0.00 | 80,411.0000 | 0 | 164.41% | 0.00% |
| March 25, 2024 | MIRA PHARMACEUTICALS, INC. | $MIRA | Jerman Michael Allen | Director | A | Nonqualified Stock Option (right to buy) | 50000 | $0.00 | 25,000.0000 | 0 | 0.00% | 0.00% |